Paper26558795
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B and 8 others. Hepatol Int, 2016. Cited by 134 papers, by iCite.
Cite this record
ConductScience Library. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Papers, record 26558795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26558795
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Cirrhosis | Major topic |
| Liver Neoplasms | Major topic |
| Non-alcoholic Fatty Liver Disease | Major topic |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Recurrence, Local | |
| Prognosis | |
| Retrospective Studies | |
| Risk Factors | |
| Survival Analysis |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21374666 | Management of hepatocellular carcinoma: an update. | Hepatology | 2011 | https://conductscience.org/library/papers/21374666 | PubMed |
| 2 | 16256907 | Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. | J Am Coll Surg | 2005 | https://conductscience.org/library/papers/16256907 | PubMed |
| 3 | 22251466 | Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. | Hepatobiliary Pancreat Dis Int | 2012 | https://conductscience.org/library/papers/22251466 | PubMed |
| 4 | 23041539 | Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. | Clin Gastroenterol Hepatol | 2012 | https://conductscience.org/library/papers/23041539 | PubMed |
| 5 | 17617329 | Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. | J Am Coll Surg | 2007 | https://conductscience.org/library/papers/17617329 | PubMed |
| 6 | 21898753 | Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. | Diabetes Metab Res Rev | 2012 | https://conductscience.org/library/papers/21898753 | PubMed |
| 7 | 20666689 | Population-based risk factors and resource utilization for HCC: US perspective. | Curr Med Res Opin | 2010 | https://conductscience.org/library/papers/20666689 | PubMed |
| 8 | 19224838 | Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19224838 | PubMed |
| 9 | 24990270 | Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. | BMC Gastroenterol | 2014 | https://conductscience.org/library/papers/24990270 | PubMed |
| 10 | 20209604 | The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. | Hepatology | 2010 | https://conductscience.org/library/papers/20209604 | PubMed |
| 11 | 15915461 | Design and validation of a histological scoring system for nonalcoholic fatty liver disease. | Hepatology | 2005 | https://conductscience.org/library/papers/15915461 | PubMed |
| 12 | 21128245 | Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. | Int J Cancer | 2011 | https://conductscience.org/library/papers/21128245 | PubMed |
| 13 | 2819932 | Diabetes mellitus and primary hepatocellular carcinoma. | Q J Med | 1986 | https://conductscience.org/library/papers/2819932 | PubMed |
| 14 | 12419825 | The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. | Carcinogenesis | 2002 | https://conductscience.org/library/papers/12419825 | PubMed |
| 15 | 25632192 | Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/25632192 | PubMed |
| 16 | 20432259 | Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. | Hepatology | 2010 | https://conductscience.org/library/papers/20432259 | PubMed |
| 17 | 16006003 | Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. | J Hepatol | 2005 | https://conductscience.org/library/papers/16006003 | PubMed |
| 18 | 19818310 | NASH and HCC. | Clin Liver Dis | 2009 | https://conductscience.org/library/papers/19818310 | PubMed |
| 19 | 21306970 | Hepatocellular cancer in the non-cirrhotic liver. | J Visc Surg | 2011 | https://conductscience.org/library/papers/21306970 | PubMed |
| 20 | 23302015 | Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. | J Gastroenterol Hepatol | 2013 | https://conductscience.org/library/papers/23302015 | PubMed |
Cited by91
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 134 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42450325 | Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450325 | PubMed |
| 42305340 | Assessing hepatosteatosis in endogenous Cushing's syndrome: the hepatic steatosis index as a reliable diagnostic tool. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42305340 | PubMed |
| 42274972 | Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers. | Hepatol Int | 2026 | https://conductscience.org/library/papers/42274972 | PubMed |
| 42162172 | Bioinformatics and experimental validation of druggable targets in non-alcoholic fatty liver disease. | Sci Rep | 2026 | https://conductscience.org/library/papers/42162172 | PubMed |
| 41607858 | The Emerging Challenge of Non-Cirrhotic MASLD-Related Hepatocellular Carcinoma: Etiology, Immunopathology, and Precision Oncology. | Liver Cancer | 2026 | https://conductscience.org/library/papers/41607858 | PubMed |
| 41546486 | Progression to Decompensation of Severe Fibrosis Compared to Cirrhosis in MASLD: A Systematic Review and Meta-Analysis. | Liver Int | 2026 | https://conductscience.org/library/papers/41546486 | PubMed |
| 41476776 | Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/41476776 | PubMed |
| 41439075 | Intracardiac Mass Reveals Hepatocellular Carcinoma: A Rare Case of Cardiac Metastasis. | Cureus | 2025 | https://conductscience.org/library/papers/41439075 | PubMed |
| 41097767 | Association of TP53 with Defective Long Chain 3-Hydroxy acyl-CoA Dehydrogenase Induced Non-Cirrhotic Hepatocellular Carcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097767 | PubMed |
| 41079925 | Immunotherapy resistance in MASLD-related hepatocellular carcinoma: special immune microenvironment and gut microbiota. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/41079925 | PubMed |
| 40869967 | Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40869967 | PubMed |
| 40704067 | Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis. | JHEP Rep | 2025 | https://conductscience.org/library/papers/40704067 | PubMed |
| 40385594 | Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort study. | Ther Adv Chronic Dis | 2025 | https://conductscience.org/library/papers/40385594 | PubMed |
| 40200415 | Characterization of non-alcoholic fatty liver disease-related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid. | Ultrasonography | 2025 | https://conductscience.org/library/papers/40200415 | PubMed |
| 40103882 | HEPNET Position Statement-I, Case Definition, Classification, Screening & Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Pakistan: A Resource for Primary and Secondary Care Physicians. | Pak J Med Sci | 2025 | https://conductscience.org/library/papers/40103882 | PubMed |
| 40041922 | Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40041922 | PubMed |
| 39500609 | Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study. | BMJ Open | 2024 | https://conductscience.org/library/papers/39500609 | PubMed |
| 39337628 | Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337628 | PubMed |
| 38911205 | What should be the best approach post-liver resection in non-viral non-cirrhotic hepatocellular carcinoma? | Hepatobiliary Surg Nutr | 2024 | https://conductscience.org/library/papers/38911205 | PubMed |
| 38852583 | EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Obes Facts | 2024 | https://conductscience.org/library/papers/38852583 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26558795
GET https://conductscience.org/api/papers/v1/26558795/references?page=2